unPAUSED with Dr. Mary Claire Haver

chevron_right

GLP-1s and Midlife Metabolism: Dr. Rocio Salas-Whalen Breaks Down the Science of Weight Loss and Menopause: Part 1

whatshot 78 snips

Nov 11, 2025

Guest

Rocio Salas-Whalen

Dr. Rocio Salas-Whalen, a triple board-certified internist and founder of New York Endocrinology, joins the conversation to discuss GLP-1 medications and their impact on midlife women. She explains how these drugs redefine obesity treatment as a chronic condition influenced by hormones and metabolism. The discussion dives into why estrogen decline leads to weight gain and abdominal fat, how GLP-1s can help, and the significance of preserving muscle mass during weight loss. Dr. Salas-Whalen also introduces her GPS protocol, combining GLP-1s with protein and strength training.

01:03:25

forum

Ask episode

web_stories

AI Snips

view_agenda

Chapters

menu_book

Books

auto_awesome

Transcript

info_circle

Episode notes

insights

INSIGHT

From Diabetes Drug To Cultural Phenomenon

GLP-1s originated as diabetes drugs with decades of safety data, then expanded to obesity treatment.
Public perception shifted rapidly once weight-loss effects became visible in culture.

volunteer_activism

ADVICE

Offer GLP-1s Sooner When Biology Prevails

Consider GLP-1s earlier for patients who have already tried diet and exercise without lasting results.
Don't force patients to 'earn' medications after exhausting other options when biology drives weight.

question_answer

ANECDOTE

Patient Breakthrough Inspired A Book

Dr. Rocio Salas-Whalen shared a patient who cried upon hearing obesity wasn't their fault.
That visit inspired her book and reframed obesity as a medical, not moral, issue.

Get the Snipd Podcast app to discover more snips from this episode

GLP‑1s improve metabolic health beyond weight

01:10 • 1min

chevron_right

Why midlife weight gain is common

02:11 • 3min

chevron_right

How GLP‑1s work biologically

05:13 • 4min

chevron_right

Dr. Salas‑Whalen's path to obesity medicine

08:47 • 40sec

chevron_right

Why she titled her book Weightless

09:27 • 5min

chevron_right

Reframing obesity as a treatable disease

14:55 • 34sec

chevron_right

When GLP‑1 should be considered first

15:30 • 2min

chevron_right

Hormonal shifts in midlife drive fat redistribution

17:55 • 6min

chevron_right

What body composition really measures

24:23 • 2min

chevron_right

How to measure body composition clinically

26:29 • 32sec

chevron_right

Are GLP‑1s a midlife game changer?

27:01 • 33sec

chevron_right

GLP‑1s alongside hormone therapy in midlife

27:34 • 1min

chevron_right

Pediatric approvals and younger patients

28:39 • 11sec

chevron_right

How to protect muscle during rapid weight loss

28:50 • 2min

chevron_right

GPS protocol: GLP‑1 plus protein and strength

30:43 • 1min

chevron_right

Acceptable muscle loss during weight reduction

32:11 • 2min

chevron_right

Is long‑term GLP‑1 therapy necessary?

34:13 • 3min

chevron_right

Should GLP‑1s be used for cosmetic, short‑term goals?

37:06 • 3min

chevron_right

When slim patients might still need GLP‑1s

40:20 • 6min

chevron_right

What is microdosing and does it help?

46:47 • 2min

chevron_right

How visceral fat and inflammation improve on GLP‑1s

48:39 • 2min

chevron_right

Drivers of the obesity epidemic

50:31 • 2min

chevron_right

Transgenerational and traumatic contributors to obesity

Risks of prescribing GLP‑1s without proper training

58:03 • 2min

chevron_right

Why obesity prevalence soared

59:34 • 46sec

chevron_right

Commercialization and telemedicine prescribing trends

01:00:20 • 2min

chevron_right

Common GLP‑1 side effects and management

Dose escalation and individual response variability

01:04:40 • 30sec

chevron_right

Frequency of serious adverse events

• Mentioned in 4 episodes

Weightless

Kandi Steiner

Weightless by Kandi Steiner is a New Adult, Contemporary Romance novel that follows Natalie, an eighteen-year-old graduate struggling with her identity and body image. The story unfolds as she begins training sessions with Rhodes, a brooding and complex character, leading to a journey of self-discovery and romance. The novel explores themes of angst, mystery, and personal growth, set against the backdrop of a small town with its own secrets.

Are GLP-1 medications a game-changer for women in midlife—or just another quick fix? In this conversation, triple Board-certified in Obesity Medicine; fellowship-trained in Endocrinology, Diabetes & Metabolism Dr. Rocio Salas-Whalen joins Dr. Mary Claire Haver to cut through the hype and share what women really need to know about Ozempic, Wegovy, Mounjaro, and the science behind sustainable weight loss.

Dr. Salas-Whalen, founder of New York Endocrinology and author of the upcoming book Weightless, explains why GLP-1 receptor agonists represent a fundamental shift in how we understand and treat obesity—not as a willpower problem, but as a chronic medical condition with biological drivers including hormones, genetics, and metabolism.

For women navigating perimenopause and menopause, the conversation gets even more specific. Dr. Salas-Whalen breaks down why estrogen decline drives fat redistribution to the abdomen, increases visceral fat, and makes it nearly impossible to lose weight using the same strategies that worked before. She reveals how GLP-1 medications can address the metabolic changes of midlife while protecting what matters most: muscle mass.

Dr. Salas-Whalen shares her clinical experience treating thousands of patients and addresses the viral misinformation circulating online. She explains why obesity is a transgenerational disease influenced by genetics, environment, food accessibility, and even childhood trauma—not personal failure.

Guest links:

Meet Your Endocrinologist - Dr. Salas-Whalen (NY Endocrinology)

Dr. Rocio Salas-Whalen (Instagram)

Books

“Weightless: A Doctor's Guide to GLP-1 Medications, Sustainable Weight Loss, and the Health You Deserve” by Dr. Rocio Salas-Whalen

Articles

Loss of Visceral Fat is Associated with a Reduction in Inflammatory Status in Patients with Metabolic Syndrome (Molecular Nutrition and Food Research)

Increased visceral fat and decreased energy expenditure during the menopausal transition (International Journal of Obesity)

Sex-specific body fat distribution predicts cardiovascular ageing (European Heart Journal)

Association between metabolic healthy obesity and female infertility: the national health and nutrition examination survey, 2013–2020 (BMC Public Health)

The discovery and development of GLP-1 based drugs that have revolutionized the treatment of obesity (PNAS)

Skeletal Muscle as Endocrine Organ (Advances in Experimental Medicine and Biology)